Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial

Bibliographic Details
Main Authors:	Becker, F, Dakin, H, Reed, S, Li, Y, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Gray, A, Hernandez, A, Holman, R
Format:	Conference item
Published:	Springer Verlag 2018

Similar Items